Media & Press relations

Our latest press releases

December 04, 2025

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

bioMérieux, a world leader in the field of in vitro diagnostics, today announced the launch of its immunoassay endocrinology offer for equine health, consisting of VIDAS® Equine INSULIN and VIDAS® Equine ACTH.

Discover more

Swipe for more

December 01, 2025

bioMérieux Honored with Multiple 2025 IMV ServiceTrak™ Clinical Laboratory Awards for Diagnostic Excellence

bioMérieux received nine 2025 IMV ServiceTrak™ Clinical Laboratory Awards for excellence in Immunoassay Analyzers, ID/AST Systems, Molecular Diagnostics and Blood Culture Systems.

Read more
November 05, 2025

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

Oxford Nanopore Technologies and bioMérieux have announced the launch of AmPORE-TB, a Research Use Only (RUO) solution for the rapid characterization of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex, using Oxford Nanopore sequencing technology.

Read more
November 04, 2025

Third-Quarter 2025 Business Review

bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2025. Consolidated sales amounted to €2,992 million for the first nine months of 2025 versus €2,871 million for the prior-year period, representing a growth of +4.2% as reported.

Read more